In June 2021, Exactech issued a recall of its Connexion GXL acetabular polyethylene hip implant liners. In February 2022, a recall was issued for Exactech knee and ankle implants that contained the same polyethylene used in the hip implants. The knee implant systems are the…
The number of product liability lawsuits focusing on paraquat’s alleged tie to Parkinson’s, a degenerative brain disease that leads to loss of muscle coordination, continues to grow. In June, the Judicial Panel on Multidistrict Litigation (JPML) ordered all paraquat lawsuits to be consolidated into the U.S.…
Millions of Americans currently suffer from heart failure, and ventricular assist devices are a popular tool to assist people with advanced heart failure to return to normalcy. The HeartWare Ventricular Assist Device (HVAD) has been implanted into more than 19,000 patients. HeartWare, later acquired by…
The Supreme Court has rejected an appeal from Johnson & Johnson seeking to undo a damages award against it over allegations that asbestos in its talc powder products caused women to develop cancer. The company must now pay $2.1 billion in damages to 20 women…
The recent unsuccessful attempt by Zimmer Biomet Inc. to undo a $3.55 million verdict regarding its defective M2a Magnum hip implant shows how the company continues to evade responsibility for the pain and suffering inflicted on patients by their flawed and dangerous implant. A federal…
According to recent studies the widely used bladder drug Elmiron may cause eye damage. Recent reports suggest that the drug — known as pentosan polysulfate sodium and used by hundreds of thousands of people for decades — may be toxic to the retina, the light-sensing…
The U.S. Food and Drug Administration in February requested that weight loss drug Belviq be pulled from the market due to cancer concerns. Now, a New York woman named Barbara Zottola has filed a class action lawsuit against the drug’s manufacturer, claiming it knew about…
Following the FDA’s recent recall of Zantac and other ranitidine medications, a major pharmaceutical company is voluntarily taking a related prescription drug, Nizatidine, off the market. On April 1, 2020, the FDA confirmed that ranitidine products could produce high levels of a possible cancer-causing substance…
The U.S. Food and Drug Administration is advising consumers who take Zantac, or generic forms of ranitidine, to stop taking the drug following research linking it to a cancer-causing agent. The advisory comes as part of the FDA’s newly issued request for the immediate removal…
A decision to coordinate all 141 current lawsuits against the makers of heartburn drug Zantac before a single federal judge in West Palm Beach, Fla. could streamline the path for all those seeking compensation and justice for their suffering. It could also help thousands of…
